CD274 and neoplasm: Moreover, the analysis of immunological blood parameters across three different models indicates that triple therapy decreased PD-L1 expression most efficiently in LLC as compared with C51 and CT26 models in addition to the upregulation of PD-1 checkpoint molecule in the latter two tumor models, representing the resistance mechanism to the triple therapy.